FK962, a novel enhancer of somatostatin release, exerts cognitive-enhancing actions in rats

European Journal of Pharmacology

Volumn 527, Issue 1-3, 2005, Pages 111-120

  Tokita, Kenichi ^a   Inoue, Tatsuo ^a   Yamazaki, Shunji ^a   Wang, Feng ^a   Yamaji, Takayuki ^a   Matsuoka, Nobuya ^a   Mutoh, Seitaro ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

FK962; Memory; Passive avoidance; Somatostatin; Water maze; Whole cell patch clamp

Indexed keywords

CALCIUM CHANNEL; FK 962; N (1 ACETYLPIPERIDIN 4 YL) 4 FLUOROBENZAMIDE; NOOTROPIC AGENT; POTASSIUM ION; SCOPOLAMINE; SOMATOSTATIN; UNCLASSIFIED DRUG;

AMNESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN DAMAGE; BRAIN NERVE CELL; BRAIN SLICE; CELL ACTIVATION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG RELEASE; EVOKED RESPONSE; HIPPOCAMPUS; MAGNOCELLULAR NUCLEUS; MALE; MAZE TEST; NERVE CONDUCTION; NERVOUS SYSTEM; NONHUMAN; OLIVARY NUCLEUS; PATCH CLAMP; PRIORITY JOURNAL; RAT; SOMATOSTATIN RELEASE; TASK PERFORMANCE; WHOLE CELL;

AGING; AMNESIA; ANIMALS; ANIMALS, NEWBORN; AVOIDANCE LEARNING; BASAL NUCLEUS OF MEYNERT; BENZAMIDES; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMBRANE POTENTIALS; NEURONS; NOOTROPIC AGENTS; PATCH-CLAMP TECHNIQUES; PIPERAZINES; PIPERIDINES; POTASSIUM; RATS; RATS, INBRED F344; SCOPOLAMINE; SOMATOSTATIN;

EID: 28544441888     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.10.022     Document Type: Article

References (63)

1. 2+ currents in rod and cone photoreceptors of the salamander retina J. Neurosci. 20 2000 929 936
2. R. Anwyl Modulation of vertebrate neuronal calcium channels by transmitters Brain Res. Brain Res. Rev. 16 1991 265 281
3. D.M. Araujo, P.A. Lapchak, B. Collier, and R. Quirion Evidence that somatostatin enhances endogenous acetylcholine release in the rat hippocampus J. Neurochem. 55 1990 1546 1555
4. R.T. Bartus, R.L. Dean III, B. Beer, and A.S. Lippa The cholinergic hypothesis of geriatric memory dysfunction Science 217 1982 408 417
5. G. Benzi, and A. Moretti Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease? Eur. J. Pharmacol. 346 1998 1 13
6. G. Bissette, and B. Myers Somatostatin in Alzheimer's disease and depression Life Sci. 51 1992 1389 1410
7. S. Boehm, and H. Betz Somatostatin inhibits excitatory transmission at rat hippocampal synapses via presynaptic receptors J. Neurosci. 17 1997 4066 4075
8. G. Bonanno, B. Parodi, S. Cafaggi, and M. Raiteri Somatostatin release from rat cerebral cortex synaptosomes J. Neurochem. 57 1991 1258 1264
9. S.D. Brinkman, and S. Gershon Measurement of cholinergic drug effects on memory in Alzheimer's disease Neurobiol. Aging 4 1983 139 145
10. V. Chan-Palay Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on Vibratome sections: coexistence with neuropeptide Y neurons, and effects in Alzheimer-type dementia J. Comp. Neurol. 260 1987 201 223
11. J.T. Coyle, D.L. Price, and M.R. DeLong Alzheimer's disease: a disorder of cholinergic innervation Science 219 1983 1184 1190
12. P. Davies, and A.J.F. Maloney Selective loss of central cholinergic neurons in Alzheimer's disease Lancet ii 1976 1403
13. P. Davies, R. Katzman, and R.D. Terry Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer senile dementia Nature 288 1980 279 280
14. R.S. Doody Current treatments for Alzheimer's disease: cholinesterase inhibitors J. Clin. Psychiatry 64 suppl 9 2003 11 17
15. J. Epelbaum, Y. Lamour, A. Enjalbert, M. Hamon, r.P. Duta, and C. Kordon Modifications in the cortical regional distribution of choline acetyltransferase, somatostatin and somatostatin binding sites in the normal rat and following lesion of the nucleus basalis Brain Res. 371 1986 376 379
16. J. Epelbaum, P. Dournaud, M. Fodor, and C. Viollet The neurobiology of somatostatin Crit. Rev. Neurobiol. 8 1994 25 44
17. L.W. Fitzgerald, and C.P.J. Dokla Morris water task impairment and hypoactivity following cysteamine-induced reductions of somatostatin-like immunoreactivity Brain Res. 505 1989 246 250
18. J.J. Hagan, and R.G.M. Morris The cholinergic hypothesis of memory: a review of animal experiments L.L. Iversen S.D. Iversen S.H. Snyder Handbook of Psychopharmacology: Psychopharmacology of the Aging Nervous System vol. 20 1988 Plenum Press New York 237 323
19. O.P. Hamill, A. Marty, E. Neher, B. Sakmann, and F.J. Sigworth Improved patch-clamp techniques for high-resolution current recording from cells and cell free membrane patches Pflugers Arch. 391 1981 85 100
20. D.J. Hepler, G.L. Wenk, B.L. Cribbs, D.S. Olton, and J.T. Coyle Memory impairments following basal forebrain lesions Brain Res. 346 1985 8 14
21. B. Hille G protein-coupled mechanisms and nervous signaling Neuron 9 1992 187 195
22. B. Hille Modulation of ion-channel function by G-protein-coupled receptors Trends Neurosci. 17 12 1994 531 536
23. S.R. Ikeda, and G.G. Schofield Somatostatin blocks a calcium current in rat sympathetic neurons J. Physiol. 409 1989 221 240
24. +-evoked release of somatostatin from rat hippocampal slices Brain Res. 892 2001 111 117
25. 2+ channels in freshly dissociated rat hippocampal neurons J. Neurophysiol. 74 1995 1028 1036
26. O. Johansson, T. Hökfelt, and R.P. Elde Immunohistochemical distribution of somatostatin-like immunoreactivity in the central nervous system of the adult rat Neuroscience 13 1984 265 339
27. A. Kay, and R.K.S. Wong Isolation of neurons suitable for patch-clamping from adult mammalian central nervous system J. Neurosci. Methods 16 1986 227 238
28. J.F.R. König, and R.A. Klippel The rat brain: a stereotaxic atlas of the forebrain and lower parts of brainstem 1963 Williams and Wilkins Baltimore
29. P. Kubanis, and S.F. Zornetzer Age-related behavioral and neurobiological changes: a review with an emphasis on memory Behav. Neural Biol. 31 1981 115 172
30. C. Léránth, and M. Frotscher Cholinergic innervation of hippocampal GAD- and somatostatin-immunoreactive commissural neurons J. Comp. Neurol. 261 1987 33 47
31. V. Luine, D. Bowling, and M. Hearns Spatial memory deficits in aged rats: contributions of monoaminergic systems Brain Res. 537 1990 271 278
32. J.R. Mancillas, G.R. Siggins, and F.E. Bloom Somatostatin selectively enhances acetylcholine-induced excitations in rat hippocampus and cortex Proc. Natl. Acad. Sci. U.S.A. 83 1986 7518 7521
33. D. Marthe-Sørenssen, P.L. Wood, D.L. Cheney, and E. Costa Modulation of the turnover rate of acetylcholine in rat brain by intraventricular injections of thyrotropin-releasing hormone, somatostatin, neurotensin and angiotensin II J. Neurochem. 31 1978 685 691
34. N. Matsuoka, and T.G. Aigner FK960 [N-(4-acetyl-1-piperazinyl)-p- fluorobenzamide monohydrate], a novel potential antidementia drug, improves visual recognition memory in rhesus monkeys: comparison with physostigmine J. Pharmacol. Exp. Ther. 280 1997 1201 1209
35. N. Matsuoka, S. Kaneko, and M. Satoh Somatostatin augments long-term potentiation of the mossy fiber-CA3 system in guinea-pig hippocampal slices Brain Res. 553 1991 188 194
36. N. Matsuoka, N. Maeda, Y. Ohkubo, and I. Yamaguchi Differential effects of physostigmine and pilocarpine on the spatial memory deficits produced by two septo-hippocampal deafferentations in rats Brain Res. 559 1991 233 240
37. N. Matsuoka, N. Maeda, M. Yamazaki, Y. Ohkubo, and I. Yamaguchi Effects of FR121196, a novel cognitive enhancer, on the memory impairment of rats in passive avoidance and radial arm maze tasks J. Pharmacol. Exp. Ther. 263 1992 436 444
38. N. Matsuoka, N. Maeda, I. Yamaguchi, and M. Satoh Possible involvement of brain somatostatin in the memory formation of rats and the cognitive enhancing action of FR121196 in passive avoidance task Brain Res. 642 1994 11 19
39. N. Matsuoka, M. Yamazaki, and I. Yamaguchi Changes in brain somatostatin in memory deficient rats: comparison with cholinergic markers Neuroscience 66 1995 617 626
40. R.K. McNamara, and R.W. Skelton The neuropharmacological and neurochemical basis of place learning in the Morris water maze Brain Res. Brain Res. Rev. 18 1993 33 49
41. R.G.M. Morris, E. Anderson, G.S. Lynch, and M. Baudry Selective impairment of learning and blockade of long-term potentiation by an N-methyl-d-aspartate receptor antagonist, AP5 Nature 319 1986 774 776
42. A. Nordberg, and A.L. Svensson Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology Drug Safety 19 1998 465 480
43. Y. Oda Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system Pathol. Int. 49 1999 921 937
44. M. Ohno, S. Shibata, T. Yamamoto, and S. Watanabe Working memory deficits following muscarinic blockade combined with depletion of brain somatostatin in rats Brain Res. 610 1993 348 353
45. M. Ohno, M. Kikusui, A. Yoshimatsu, T. Yamamoto, and S. Watanabe Somatostatin alleviates impairment of working memory induced by hippocampal muscarinic M1 receptor blockade in rats Eur. J. Pharmacol. 271 1994 557 560
46. E.K. Perry, B.E. Tomlinson, G. Blessed, K. Bergmann, P.H. Gibson, and R.H. Perry Correlation of cholinergic abnormalities with senile plaques and mental scores in senile dementia Br. Med. J. 2 1978 1457 1459
47. F. Ponzio, G. Calderini, G. Lomuscio, G. Vantini, G. Toffano, and S. Algeri Changes in monoamines and their metabolite levels in some brain regions of aged rats Neurobiol. Aging 3 1982 23 29
48. S.L. Rogers, M.R. Farlow, R.S. Doody, R. Mohs, L.T. Friedhoff The Donepezil Study Group A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease Neurology 50 1998 136 145
49. G. Schettini Brain somatostatin: receptor-coupled transducting mechanisms and role in cognitive functions Pharmacol. Res. 23 3 1991 203 214
50. T.J. Teyler, and P. Discenna Long-term potentiation as a candidate mnemonic device Brain Res. Brain Res. Rev. 7 1984 15 28
51. V.S. Thoss, J. Perez, D. Duc, and D. Hoyer Embryonic and postnatal mRNA distribution of five somatostatin receptor subtypes in the rat brain Neuropharmacology 34 1995 1673 1688
52. K. Tokita, S. Yamazaki, M. Yamazaki, N. Matsuoka, and S. Mutoh Combination of a novel antidementia drug FK960 with donepezil synergistically improves memory deficits in rats Pharmacol. Biochem. Behav. 73 2002 511 519
53. R.W. Tsien, D. Lipscombe, D.V. Madison, K.R. Bley, and A.P. Fox Multiple types of neuronal calcium channels and their selective modulation Trends Neurosci. 11 1988 432 438
54. L. Vécsei, I. Bollók, and G. Telegdy Intracerebroventricular somatostatin attenuates electroconvulsive shock-induced amnesia in rats Peptides 4 1983 293 295
55. A. Vezzani, A. Monno, M. Rizzi, A. Galli, M. Barrios, and R. Samanin Somatostatin release is enhanced in the hippocampus of partially and fully kindled rats Neuroscience 51 1992 41 46
56. F. Viana, and B. Hille Modulation of high voltage-activated calcium channels by somatostatin in acutely isolated rat amygdaloid neurons J. Neurosci. 16 1996 6000 6011
57. 2+ channel currents by a novel antidementia drug N-(4-acetyl-1- piperazinyl)-p-fluorobenzamide monohydrate (FK960) in rat hippocampal neurons J. Pharmacol. Exp. Ther. 308 2004 120 126
58. H.L. Wang, T. Reisine, and M. Dichter Somatostatin-14 and somatostatin-28 inhibit calcium currents in rat neocortical neurons Neuroscience 38 1990 335 342
59. Z.P. Wang, S.Y. Man, and F. Tang Age-related changes in the contents of neuropeptides in the rats brain and pituitary Neurobiol. Aging 14 1993 529 534
60. P.L. Wood, D.L. Cheney, and E. Costa Modulation of the turnover rate of hippocampal acetylcholine by neuropeptides: possible site of action of α-melanocyte-stimulating hormone, adrenocorticotrophic hormone and somatostatin J. Pharmacol. Exp. Ther. 209 1979 97 103
61. M. Yamazaki, N. Matsuoka, N. Maeda, K. Kuratani, Y. Ohkubo, and I. Yamaguchi FR121196, a potential antidementia drug, ameliorates the impaired memory of rat in the Morris water maze J. Pharmacol. Exp. Ther. 272 1995 256 263
62. M. Yamazaki, N. Matsuoka, N. Maeda, Y. Ohkubo, and I. Yamaguchi FK960 N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate ameliorates the memory deficits in rats through a novel mechanism of action J. Pharmacol. Exp. Ther. 279 1996 1157 1173
63. W.Q. Zhang, W.R. Mundy, L. Thai, P.M. Hudson, M. Gallagher, H.A. Tilson, and J.S. Hong Decreased glutamate release correlates with elevated dynorphin content in the hippocampus of aged rats with spatial learning deficits Hippocampus 1 1991 391 397